ARE H-2-RECEPTOR ANTAGONISTS SAFE OVER-THE-COUNTER DRUGS

被引:20
作者
ANDERSEN, M
SCHOU, JS
机构
关键词
D O I
10.1136/bmj.309.6953.493
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:493 / 494
页数:2
相关论文
共 9 条
[1]   ADVERSE REACTIONS TO H2-RECEPTOR ANTAGONISTS IN DENMARK BEFORE AND AFTER TRANSFER OF CIMETIDINE AND RANITIDINE TO OVER-THE-COUNTER STATUS [J].
ANDERSEN, M ;
SCHOU, JS .
PHARMACOLOGY & TOXICOLOGY, 1991, 69 (04) :253-258
[2]   SAFETY IMPLICATIONS OF THE OVER-THE-COUNTER AVAILABILITY OF H-2-ANTAGONISTS [J].
ANDERSEN, M ;
SCHOU, JS .
DRUG SAFETY, 1993, 8 (03) :179-185
[3]   DRUGS - FROM PRESCRIPTION ONLY TO PHARMACY ONLY [J].
BARBER, N .
BRITISH MEDICAL JOURNAL, 1993, 307 (6905) :640-640
[4]   TREATMENT OF PEPTIC-ULCERS CAUSED BY HELICOBACTER-PYLORI [J].
GRAHAM, DY .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (05) :349-350
[5]   OVER-THE-COUNTER HISTAMINE H-2-RECEPTOR ANTAGONISTS - HOW WILL THEY AFFECT THE TREATMENT OF ACID-RELATED DISEASES [J].
HOLT, S .
DRUGS, 1994, 47 (01) :1-11
[6]  
KRISTENSEN K, 1992, LANCET, V339, P418
[7]   THE RISKS AND BENEFITS OF AN RX-TO-OTC SWITCH - THE CASE OF OVER-THE-COUNTER H2-BLOCKERS [J].
OSTER, G ;
HUSE, DM ;
DELEA, TE ;
COLDITZ, GA ;
RICHTER, JM .
MEDICAL CARE, 1990, 28 (09) :834-852
[8]  
1991, SWISS PHARMA, V13, pR3A
[9]  
1994, CURRENT PROBLEMS PHA, V20, P4